Skip to main content
CGEN logo

CGEN · Compugen Ltd

Track CGEN — free
$2.41 +0.00 (+0.00%) At close · Aug 14
Market Cap
$228.29M
Shares
94.72M

Compugen Ltd Earnings Call Transcripts

Every quarterly earnings call for Compugen Ltd (CGEN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-03
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
Results not yet reported
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2026-05-19
Compugen Presentation at 2026 Stifel Virtual Targeted Oncology Forum
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-18
Earnings conference call (announced in 6-K)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-13
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2025-12-31
Compugen Ltd Q4 FY2025 Earnings Call
Confident tone AstraZeneca partnership and rilvegostomig COM701 / MAIA ovarian trial GS-0321 / Gilead partnership
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Compugen Ltd Q3 FY2025 Earnings Call
Confident tone Fc reduced anti-TIGIT differentiation AstraZeneca bispecific Rilfrogostomab MYO ovarian platform trial (COM701)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Compugen Ltd Q2 FY2025 Earnings Call
Positive tone Partnership with AstraZeneca on rilvegostomig TIGIT competitive landscape and class validation Financial position and runway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-09
Compugen Ltd Q1 FY2025 Earnings Call
Positive tone TIGIT landscape and Fc-inactive thesis AstraZeneca partnership and rilvegostomig COM701 in platinum-sensitive ovarian cancer
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Compugen Ltd Q4 FY2024 Earnings Call
Positive tone TIGIT landscape and COM902 differentiation AstraZeneca partnership / rilvegostomig COM701 in platinum-sensitive ovarian cancer
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Compugen Ltd Q3 FY2024 Earnings Call
Positive tone COM701 ovarian cancer development Biomarker strategy Adaptive platform trial design
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Compugen Ltd Q1 FY2024 Earnings Call
Positive tone COM701 / MSS-CRC Liver Metastasis Biomarker / PVRL2 Strategy AstraZeneca Partnership / Rilvegostomig
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-09-30
Compugen Ltd Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Compugen Ltd Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Compugen Ltd Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-27
Compugen Ltd Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-29
Compugen Ltd Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-21
Compugen Ltd Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Compugen Ltd Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Compugen Ltd Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Compugen Ltd Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Compugen Ltd Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Compugen Ltd Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Compugen Ltd Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Compugen Ltd Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Compugen Ltd Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1119774 CUSIP M25722105 13F (30d) 76 filings 74 filers Visit website Investor relations